Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid

Leuk Lymphoma. 2019 May;60(5):1328-1330. doi: 10.1080/10428194.2018.1522436. Epub 2018 Dec 11.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Arsenic Trioxide / administration & dosage
  • Blood Transfusion* / methods
  • Hospitalization*
  • Humans
  • Leukemia, Promyelocytic, Acute / diagnosis
  • Leukemia, Promyelocytic, Acute / epidemiology*
  • Leukemia, Promyelocytic, Acute / therapy*
  • Treatment Outcome
  • Tretinoin / administration & dosage

Substances

  • Tretinoin
  • Arsenic Trioxide